SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-043426
Filing Date
2021-08-17
Accepted
2021-08-17 16:02:28
Documents
14
Period of Report
2021-08-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea146062-8k_alphhealth.htm   iXBRL 8-K 42498
2 PRESS RELEASE ea146062ex99-1_alphhealth.htm EX-99.1 22546
  Complete submission text file 0001213900-21-043426.txt   310372

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ahacu-20210817.xsd EX-101.SCH 4142
4 XBRL DEFINITION FILE ahacu-20210817_def.xml EX-101.DEF 28380
5 XBRL LABEL FILE ahacu-20210817_lab.xml EX-101.LAB 37937
6 XBRL PRESENTATION FILE ahacu-20210817_pre.xml EX-101.PRE 26994
7 EXTRACTED XBRL INSTANCE DOCUMENT ea146062-8k_alphhealth_htm.xml XML 7087
Mailing Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10105
Business Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10105 6463213444
Alpha Healthcare Acquisition Corp. (Filer) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39532 | Film No.: 211182766
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences